N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide, 98.0%, 5g

6-Aminoindazole>98.0%(HPLC)(T)25g

Diethyl Ethyl(phenyl)malonate>98.0%(GC)25g

(S)-4-Benzylmorpholine-3-carboxylic acid, 95.0%, 1g

4,5-Dibromo-1H-1,2,3-triazole>98.0%(T)1g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 5g

OFLOXACIN, 95%, 400g

2-Phenoxytetrahydropyran>90.0%(GC)5mL

Orotic acid, 95%, 500g

7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbonitrile, 98%, 1g

tert-Butyl 1-formylcyclopropylcarbamate, 95.0%, 5g

2-Bromo-2-methylpropiophenone, 95.0%, 5g

3,5-Dihydroxy-4-methoxybenzoic acid, 97%, 250mg